Haploidentical PBMC Transplant for Severe Congenital Anemias

NCT00977691 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

PROCEDURE: PBSC Transplant
DRUG: Alemtuzumab
DRUG: Sirolimus
DRUG: Cyclophosphamide
PROCEDURE: Low Dose Irradiation

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)